Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 09-1998 | 06-1998 | 03-1998 | 12-1996 | |
| Sales | 3,442 | 3,906 | 4,584 | 2,080 | 0 |
| Gross Profit | 3,442 | 3,900 | 4,580 | 2,080 | N/A |
| Operating Expenses | 0 | 3,210 | 3,820 | 2,230 | 0 |
| Operating Income | 3,442 | 696 | 764 | -150 | N/A |
| Interest Expense | 0 | 10 | 9 | 9 | 0 |
| Other Income | 0 | -16 | -15 | -1 | 0 |
| Pre-tax Income | 3,442 | 670 | 740 | -160 | 0 |
| Income Tax | N/A | 80 | 0 | 0 | N/A |
| Net Income Continuous | 286 | 588 | 743 | -160 | N/A |
| Net Income | $286 | $588 | $743 | $-160 | $N/A |
| EPS Basic Total Ops | 0.03 | 0.06 | 0.08 | N/A | N/A |
| EPS Basic Continuous Ops | 0.03 | 0.06 | 0.08 | N/A | N/A |
| EPS Diluted Total Ops | 0.03 | 0.06 | 0.07 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.03 | 0.06 | 0.07 | N/A | N/A |
| EBITDA(a) | $3,442 | $836 | $874 | $-40 | $N/A |